Eric M. Dube - 04 May 2026 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: TVTX
Reported as of: 04 May 2026
Net transaction value: -$988,875
SEC form: 4
Accepted by SEC: 06 May 2026, 20:00:24 UTC
Prior SEC filing: 15 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth E. Reed, Attorney-in-Fact

Key filing fact

Eric M. Dube filed Form 4 for Travere Therapeutics, Inc. (TVTX) on 06 May 2026.

Key facts

This page summarizes Eric M. Dube's Form 4 filing for Travere Therapeutics, Inc. (TVTX).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 06 May 2026, 20:00.

Change

Previous filing in this sequence was filed on 15 Apr 2026.
Current net transaction value: -$988,875.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001763494 Primary reporting owner

Dube Eric M

Relationship: CHIEF EXECUTIVE OFFICER, Director
Address: C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DR., SUITE 300, SAN DIEGO
Signature: /s/ Elizabeth E. Reed, Attorney-in-Fact
Signature date: 06 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TVTX transaction

Common Stock

Options Exercise

Transaction value
Shares: +22,500
Change %: +5.2%
Price: $0.000000^*
Shares after: 455,386
Date: 04 May 2026
Ownership: Direct
Footnotes: F1

TVTX transaction

Common Stock

Sale

Transaction value: $988,875
Shares: -22,500
Change %: -4.9%
Price: $43.95
Shares after: 432,886
Date: 06 May 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TVTX transaction Derivative

Performance-based restricted stock units

Award

Transaction value
Shares: +45,000
Change %
Price: $0.000000^*
Shares after: 45,000
Date: 04 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,000
Exercise price
Footnotes: F1, F3

TVTX transaction Derivative

Performance-based restricted stock units

Options Exercise

Transaction value
Shares: -22,500
Change %: -50%
Price: $0.000000^*
Shares after: 22,500
Date: 04 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,500
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

On January 31, 2024, the Reporting Person was granted performance restricted stock units (PSUs) covering 45,000 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. If any such milestone is achieved on a pre-specified accelerated timeline, up to 50% additional shares attributable to such milestone achievement could vest under these PSU grants, with such additional potential shares to vest at a later date in furtherance of retention objectives. On May 4, 2026, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2026 that a performance criterion related to cumulative FILSPARI net revenue had been achieved, and contingent on continuous service by the Reporting Person, on January 31, 2027 an additional 25% of such PSUs will vest due to the timing of the achievement of such cumulative FILSPARI net revenue performance criterion.

Footnote F2

This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units.

Footnote F3

Each PSU represents a contingent right to receive one share of the Issuer's common stock at target, subject to adjustment based on the achievement of applicable performance conditions.